Csenge Advisory Group Zoetis Inc. Transaction History
Csenge Advisory Group
- $1.81 Billion
- Q4 2024
A detailed history of Csenge Advisory Group transactions in Zoetis Inc. stock. As of the latest transaction made, Csenge Advisory Group holds 5,272 shares of ZTS stock, worth $897,399. This represents 0.05% of its overall portfolio holdings.
Number of Shares
5,272
Previous 5,233
0.75%
Holding current value
$897,399
Previous $1.02 Million
16.05%
% of portfolio
0.05%
Previous 0.05%
Shares
28 transactions
Others Institutions Holding ZTS
# of Institutions
1,954Shares Held
408MCall Options Held
1.02MPut Options Held
1.09M-
Vanguard Group Inc Valley Forge, PA41.2MShares$7.02 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$6.27 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.8MShares$3.37 Billion0.16% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL16MShares$2.73 Billion2.73% of portfolio
-
Alliancebernstein L.P. New York, NY15.4MShares$2.62 Billion1.05% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $79.7B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...